W o have show11 that. cticnrotherapy wllh r i~t r o s o u r c a s a~i d ~i o l s p i n a l I r r a d~a t l o r l i s respoils1 b l c f o r gonad;^] danraqc i n our chi 1drc11 trcat.cd f o r niodu1lobl:lstoma (Ahmcd c t a l , 1983). But I he ~~r c~d c~r c c a~i d 1nflu1:ncc on p~1b1:r.l a l dcvclopnrcnl a r c u~lknowri. 40 chi ldre11(241.1: 161), who rccclvcd ;I r~: t r o s o u r e a i n 6 week c y c l e s f o r I-2yrs were followed f o r a mcan of 4 . 0 y r s ( r a~l g c 0.2-1 1 ) . 29/29 cnt.ercd o r collrplcl cd pubcrt y sporlt ancousl y, and 717 conrnrc~ici:d menses a t appropr l a i c a g c s . Tosl r c u l c~r s~z c s , c~sscsscd al 1 7 . 5~~: ; 2nd 5 . 9~1 ' 3 fronr CTX (ra~ic] 
T h e b i o l o g i c a l a c t l v i t y o f HPL o n human f e t a l e p i p h y s e a l c h o n d r o c y t e s i n c u l t u r e h a s b e e n i n v e s t i g a t e d b y s t u d y i n g t h e c a p a c i t y t o s t i m u l a t e c h o n d r o c y t e p r o l i f er a t i o n i n a c h e m i c a l l y d e f i n e d s e x u m -f r e e m e d i u m .
C h o n d r o c y t e s ( 7 0 . 0 0 0 c e l l s / w e l l ) w e r e i n c u b a t e d w i t h 1iw.l F-12 s e r u m a n d a n t i b i o t i c -f r e e m e d i u m f o r 4 8 h . T h e medium w a s t h e n a s p i r a t e d a n d r e p l a c e d b y IlCDB 1 0 4 s erum a n d a n t i b i o t i c -f r e e m e d i u m w i t h HPL ( 1 -1 0 0 n q / n l ).
C e l l s w e r e t h e n i n c u b a t e d f o r 48 h , t h e l a s t 2 4 h i n t h e p r e s e n c e o f 3~-t h y m i d i n e ( 5 u C i / m l ) . I n e a c h e x p e r i m e n t f i v e d i f f e r e n t w e l l s w e r e u s e d f o r e a c h HPL' c o n c e n t r a t i o n a n d f i v e a s c o n t r o l s .
HPL ( I n c o n c l u s i o n , H P L s t i m u l a t e s h u m a n f e t a l e p i p h y s e a l c h o n d r o c y t e p r o l i f e r a t i o n i n a s e r u m -f r e e medium a n d t h e s e r e s u l t s s u g g e s t s t h a t HPL may b e i n v o l v e d i n human f e t a l e p i p h y s e a l c a r t i l a g e m e t a b o l i s m . 
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I n s t i t u t e , Stockholm, Sweden. STIMULATION OF CHONDROCYTE DNA SYNTHESIS BY JUVENILE CHRONIC ARTHRITIS SYNDVIhL FLUID
Synovial f l u i d from p a t i e n t s w i t h j u v e n i l e chronic a r t h r i t i s (JCA) was found t o s t i m u l a t e t h e DNA s y n t h e s i s of r a t epiphyseal chondrocytes i n serum-free primary c u l t u r e s i n v i t r o . The e f f e c t was dosedependent and more pronounced than t h a t observed w i t h newborn c a l f serum. The c l o n i n g e f f i c i e n c y and colony s i z e of chondrocytes i n s o f t agar colony c u l t u r e s were
t i o n p a t t e r n of t h e chondrocyte s t i m u l a t i n g a c t i v i t y and t h e IL-1 a c t i v i t y , i n d i c a t i n g t h a t IL-1 might a c t as a chondrocyte growth f a c t o r i n v i t r o . T h i s assumption was f u r t h e r supported by experiments demonstrating a dose-re1 a t e d s t i m u l a t i o n o f chondrocyte DNA s y n t h e s i s
by n a t u r a l guinea p i g macrophage-derived IL-1 and recombinant human IL-1.
As i t has been shown t h a t t h e a r t i c u l a r c a v i t y i s v a s c u l a r l y connected w i t h nearby epiphyseal p l a t e s , our r e s u l t s might g i v e one e x p l a n a t i o n f o r t h e s t i m u l a t i o n of bone growth o f t e n seen i n t h e a f f e c t e d l i m b i n c h i l d r e n w i t h m o n o a r t h r i t i s .
E. Heinze, U. V e t t e r * , R.D. Fussganger*, W. P i r s i a * Department of P e d i a t r i c s I , I n t e r n a l Medicine, ORL U n i v e r s i t y o f Ulm, FRG
THE SULTONYLUREA GLIBENCLAMIDE DIRECTLY STIMULATES GROWTH OF CHONDROCYTES.
Glibenclamide treatlnent of hypophysectonlized r a t s augmented i ns u l i n , somatomedin, and s k e l e t a l growth. I t i s unknown i f t h e s u l f o n y l u r e a can d i r e c t l y enhance s k e l e t a l growth. Therefore chondrocytes from normal o r hypophysectomized r a t s and from human nose s e p t a l c a r t i l a g e were i s o l a t e I n a mlticentse study 76 patients with WP uicrc treated with UD, inject& 1.m. a t 41.k intervals. 18 Patients were a? therapy for 6 m, 42 for 12 m or mre. 24 Patients were previously treat& with Buserelin (daily s.c.) or Cypmtemcetate (daily p.o. ). DD was started a t a man c h m o l . age (CA) for g i r l s (n=68) a t 6.9 1 1.9 yrs (mean 5 sd) and for boys (n=8) a t 6.5 2 1.6 yrs;
Bone age ((BA) (G & 1' ) w a 9.9 + 2.0 and 11.0 + 2.6 yrs m p . C-wrth velccily in boys (n3)iuithout pretreatrent ranged ktw& 12.5 -14,3 d y r and decrrased 3.5 -5.1 d y r after m e year of therapy. In previously untrrated g i r l s the mean &rcwtk velccity decreased f m 10.7 2 3.5 (rs28) to 6.7 1 2.8 after 6 m and further to 5.3 5 2. Androstenedione ( a 4 ) basal level was 2.0 + 1.4 ml/l (n=21) and after 6 and 12 m 1.2 + 1.7 (n=X)) and 1.1 + 1.1 (~1 6 ) .
BEAS levels did not change during DD. Clinlcal s i p of pubic hair developnent decreased in boys but not in girls. In conclusion DE-treatment decreases wV, velcclty and b e mturatia?, mjulting in an m increase of adult height p w c 6 i s in boys ,
but not (yet) in girls.
